Trials Sponsors Conditions Drugs Pricing

Conditions

Orbital Neoplasms

Outcome Measures

Primary Outcomes (1)

Diagnostic accuracy
The diagnostic accuracy of 18F-FDG and 18F-AlF-FAPI PET/CT were calculated and compared to evaluate the diagnostic efficacy.
through study completion, an average of 6 months

Secondary Outcomes (3)

SUV metrics
through study completion, an average of 6 months
Tumor-to-background ratio
through study completion, an average of 6 months
Number of lesions
through study completion, an average of 6 months

Study Arms (1)

Experimental arm

EXPERIMENTAL

Experimental arm

Diagnostic Test: 18F-AlF-FAPI PET/CT, 18F-FDG PET/CT

Interventions

18F-AlF-FAPI PET/CT, 18F-FDG PET/CTDiagnostic test

Subjects with orbital neoplasms underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT for diagnosis and staging.

Experimental arm

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age3 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

patients with suspected or newly diagnosed orbital neoplasms (supporting evidence may include MRI, CT and pathology report);
patients who had scheduled both 18F-FDG and 18F-AlF-FAPI PET/CT scans;

Sponsors & Collaborators

Peking University Third Hospital
Otherlead

Study Sites (1)

Dept. of Nuclear Medicine, Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

RECRUITING

Hui Li, Dr.CONTACT86-010-82264935 huilee1990@163.com

Lingge Suo, Dr.CONTACT86-010-82264935 suolingge_1019@126.com

Hui Li, Dr.PRINCIPAL INVESTIGATOR

MeSH Terms

Conditions

Orbital Neoplasms

Condition Hierarchy (Ancestors)

Skull NeoplasmsBone NeoplasmsNeoplasms by SiteNeoplasmsEye NeoplasmsBone DiseasesMusculoskeletal DiseasesEye DiseasesOrbital Diseases

Central Study Contacts

Hui Li

CONTACT

86-010-82264935 huilee1990@163.com

Lingge Suo

CONTACT

86-010-82264935

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: DIAGNOSTIC
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

April 7, 2024

First Posted

January 24, 2025

Study Start

July 16, 2024

Actual (reported)

Primary Completion

December 31, 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Experimental arm

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Experimental arm

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations